This paper proposes and analyses a model of start-up investment. Innovative entrepreneurs are commercially inexperienced and can benefit from venture capital support. Only part of them succeed in matching with a venture capitalist while the rest must resort to standard bank finance. We consider...

Innovation meets the translation gap. Stop the madness and cure something -- Into the Valley of Death -- Clinical promise investment practice -- Velcade, a biotech success story -- biotechnology and the future of pharma -- Why pharma should care about the Valley of Death -- Porter's five forces...